Related Experiment Video
Updated: Jun 27, 2026
14:36
Combining QD-FRET and Microfluidics to Monitor DNA Nanocomplex Self-Assembly in Real-Time
Published on: August 26, 2009
Microfluidic-Driven Assembly of RNA Nanocomplexes: Design, Process Control and Translational Perspectives in
Ronan Pinto Nobrega Dos Santos1, Dana Celeste Betancourt Roldan2, Muslum Guven3
1Nanotechnology Engineering Department (PENt), Alberto Luiz Coimbra Institute for Graduate Studies and Research in Engineering (COPPE), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-594, Brazil.
Pharmaceutics
|June 26, 2026
Summary
Microfluidics precisely control RNA nanocarrier synthesis for enhanced cancer therapy delivery. This technology enables tunable particle properties and improved therapeutic efficacy, paving the way for advanced RNA nanomedicines.
Area of Science:
- Oncology
- Nanotechnology
- Biomedical Engineering
Background:
- RNA therapeutics, including mRNA, are crucial in oncology.
- Efficient delivery of RNA to target cells is essential for therapeutic success.
- Microfluidics offers precise control over RNA nanocarrier fabrication.
Purpose of the Study:
- To review microfluidic-assisted synthesis of RNA nanocarriers for cancer applications.
- To analyze material systems, device architectures, and formulation strategies.
- To explore the integration of microfluidics with tumor-on-chip models.
Main Methods:
- Laminar flow environments for reproducible encapsulation and tunable particle size.
- Microfluidic assembly of lipid nanoparticles and polymeric carriers.
- Process optimization, inline monitoring, and device geometry influence on mixing.
- Integration with tumor-on-chip platforms for preclinical evaluation.
Main Results:
- Microfluidics enables precise control over physicochemical features of RNA nanocarriers.
- Enhanced durability, bioavailability, and cellular uptake of RNA payloads.
- Reproducible synthesis of nanocarriers with tunable size and improved stability.
- Physiologically relevant evaluation of RNA nanomedicine performance in vitro.
Conclusions:
- Microfluidic precision is key to developing next-generation RNA nanomedicines.
- This technology facilitates the creation of personalized RNA-based cancer therapies.
- Microfluidics bridges technological innovation with preclinical application for improved oncology outcomes.
Related Concept Videos
02:24Regulation of Expression Occurs at Multiple Steps
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
02:24Ribosome Profiling
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...